Cover Image
29 November 2018
Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi – 27 November 2018 – There is a paucity of recent data about the epidemiology and long‐term outcomes of nonalcoholic fatty liver disease (NAFLD) in the female population. Our aim was to assess the prevalence, risk factors, and mortality of NAFLD in female adults of the United States. Data from the National Health and Nutrition Examination Survey (NHANES) III and NHANES 1999‐2014 were used. NAFLD status was determined by the U.S.
Prevalence of Nonalcoholic Fatty Liver Disease in the Female Population
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi – 27 November 2018 – There is a paucity of recent data about the epidemiology and long‐term outcomes of nonalcoholic fatty liver disease (NAFLD) in the female population. Our aim was to assess the prevalence, risk factors, and mortality of NAFLD in female adults of the United States. Data from the National Health and Nutrition Examination Survey (NHANES) III and NHANES 1999‐2014 were used. NAFLD status was determined by the U.S.
Letter to the Editor: Patient‐Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use
Patrizia Carrieri, Martin Duracinsky, Fabienne Marcellin, Jeffrey V. Lazarus – 25 November 2018
Sarcopenia and Frailty in the Prognosis of Patients on the Liver Transplant Waiting List
Maryam Ebadi, Aldo J. Montano‐Loza – 25 November 2018
Nonalcoholic Steatohepatitis Is Becoming a Top Indication for Liver Transplantation Worldwide
Mehmet Sayiner, Zobair M. Younossi – 25 November 2018
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Fabio Caputo, Marco Domenicali, Mauro Bernardi – 24 November 2018 – Between 14%‐30% of the world’s population is affected by alcohol use disorder (AUD), and excessive alcohol consumption represents the most common cause of liver disease in the western world. The clinical picture of alcoholic end‐stage liver disease is rendered extremely complex, as manifestations such as alcohol withdrawal syndrome, craving and physical dependence, as well as extrahepatic alcohol‐related diseases merge with the complications of advanced cirrhosis.
Auxiliary Partial Orthotopic Liver Transplantation for Noncirrhotic Metabolic Liver Disease: Reigniting Interest in an Old but New Technique
Mureo Kasahara, Seisuke Sakamoto, Reiko Horikawa, Akinari Fukuda – 24 November 2018
Reply
Jesús Quintero, Cristina Molera, Javier Juamperez, Susanna Redecillas, Silvia Meavilla, Raquel Nuñez, Camila García‐Volpe, Mireia del Toro, Ángels Garcia‐Cazorla, Juan Ortega, Óscar Segarra, Javier Martin de Carpi, Itxarone Bilbao, Ramon Charco – 24 November 2018
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease
Fabio Caputo, Marco Domenicali, Mauro Bernardi – 24 November 2018 – Between 14%‐30% of the world’s population is affected by alcohol use disorder (AUD), and excessive alcohol consumption represents the most common cause of liver disease in the western world. The clinical picture of alcoholic end‐stage liver disease is rendered extremely complex, as manifestations such as alcohol withdrawal syndrome, craving and physical dependence, as well as extrahepatic alcohol‐related diseases merge with the complications of advanced cirrhosis.